MOH Molina Healthcare Inc.

Molina Healthcare Plans Receive Ratings from NCQA’s Medicaid Health Insurance Plan Ratings 2016-2017

Molina Healthcare, Inc. (NYSE:MOH) today announced that its plans received ratings from the widely respected National Committee for Quality Assurance (NCQA) as part of the Medicaid Health Insurance Plan Ratings for 2016-2017. The ratings measure Medicaid health plans based on their combined HEDIS®, CAHPS® and NCQA Accreditation standards scores. Molina Healthcare’s health plans in California, Florida, Illinois, Michigan, New Mexico, Ohio, South Carolina, Texas, Utah, Washington and Wisconsin all reported measures and received health plan numerical ratings.

“We are proud that Molina health plans have been consistently accredited and rated by NCQA for quality and performance,” said J. Mario Molina, M.D., president and chief executive officer of Molina Healthcare. “The results of Molina’s health plans in NCQA’s Medicaid Health Insurance Plan Ratings illustrate continued success as we work to deliver the highest quality care to the population we’ve served for the last 36 years.”

This year, Molina Healthcare’s health plans in Michigan and Utah received overall ratings of 4 out of 5 in NCQA’s Medicaid Health Insurance Plan Ratings 2016-2017. In addition, Molina’s health plans in New Mexico, Utah and Washington are the top-rated Medicaid health plans in the state, with an overall rating of 3.5 out of 5 in New Mexico, 4 out of 5 in Utah, and 3.5 out of 5 in Washington. Full ratings may be found at www.ncqa.org.

About Molina Healthcare, Inc.

Molina Healthcare, Inc., a FORTUNE 500 company, provides managed health care services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through our locally operated health plans in 12 states across the nation and in the Commonwealth of Puerto Rico, Molina serves approximately 4.3 million members. Dr. C. David Molina founded our company in 1980 as a provider organization serving low-income families in Southern California. Today, we continue his mission of providing high quality and cost-effective health care to those who need it most. For more information about Molina Healthcare, please visit our website at molinahealthcare.com.

About NCQA

National Committee for Quality Assurance (NCQA) is a private, non-profit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations and recognizes clinicians in key clinical areas. NCQA’s HEDIS® is the most widely used performance measurement tool in health care. NCQA’s Web site (www.ncqa.org) contains information to help consumers, employers and others make more informed health care choices.

EN
29/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Molina Healthcare Inc.

Molina Healthcare Inc: 1 director

A director at Molina Healthcare Inc bought 10,000 shares at 155.937USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

Moody’s Ratings assigns a Ba2 rating to Molina’s new senior unsecured ...

New York , November 13, 2024 – Moody's Ratings (Moody's) has assigned a Ba2 rating to the new issuance of senior unsecured debt of Molina Healthcare, Inc. (Molina, NYSE: MOH). We anticipate the issuance, a private placement, to total $500 million and mature in 2033. The purpose is for general corpor...

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2024 05 17

Cash bond markets are overstating MOH's credit risk with a YTW of 6.140% relative to an Intrinsic YTW of 5.170%, while CDS markets are accurately stating credit risk with a CDS of 112bps relative to an Intrinsic CDS of 81bps. Furthermore, Moody's is materially overstating MOH's fundamental credit risk with its highly speculative Ba2 credit rating seven notches below Valens' IG3+ (A1) credit rating. Incentives Dictate Behavior™ analysis highlights mostly negative signals for credit holders. As a...

Valens Research
  • Valens Research

MOH - Valens Credit Report - 2024 02 27

Cash bond markets are overstating MOH's credit risk with a YTW of 6.033% relative to an Intrinsic YTW of 5.103%, while CDS markets are slightly overstating credit risk with a CDS of 152bps relative to an Intrinsic CDS of 83bps. Furthermore, Moody's is grossly overstating MOH's fundamental credit risk with its highly speculative Ba3 credit rating eight notches below Valens' IG3+ (A1) credit rating. Incentives Dictate BehaviorTM analysis highlights mostly negative signals for credit holders. As a...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch